Johnson & Johnson Hit With $8 Billion Jury Verdict

Johnson & Johnson will have to fork over $8-billion now that a Philadelphia jury has ruled the antipsychotic drug Risperdal can cause breast growth in men.

A guy by the name of Nicholas Murray claimed he developed breasts after being prescribed the medication when he was a kid.

Risperdal is designed to treat schizophrenia and bipolar episodes, but Murray was given it for off-label use after being diagnosed with autism.